Schizophrenia relapse, patient considerations, and potential role of lurasidone
about
Emerging pharmacological therapies in schizophrenia: what's new, what's different, what's next?Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USACariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
P2860
Schizophrenia relapse, patient considerations, and potential role of lurasidone
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@ast
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@en
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@nl
type
label
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@ast
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@en
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@nl
prefLabel
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@ast
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@en
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@nl
P2860
P3181
P356
P1476
Schizophrenia relapse, patient considerations, and potential role of lurasidone
@en
P2093
Leslie Citrome
P2860
P304
P3181
P356
10.2147/PPA.S45401
P407
P577
2016-01-01T00:00:00Z